Title : Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.

Pub. Date : 2017 Jan 3

PMID : 27768593






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The newly discovered short (9 amino acid) non-RGD S-S bridged cyclic peptide ALOS-4 (H-cycl(Cys-Ser-Ser-Ala-Gly-Ser-Leu-Phe-Cys)-OH), which binds to integrin alphavbeta3 is investigated as peptide carrier for targeted drug delivery against human metastatic melanoma. Glycine integrin subunit alpha V Homo sapiens